SCHEMBL10345889

SCHEMBL10345889

CC1(C)C(=O)N([Si](C)(C)C(C)(C)C)[C@@H]1C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7605677 1.00 MEN1 (0.32) MEN1KMT2AESR1
SCHEMBL10657556 1.00 MEN1 (0.32) MEN1KMT2AESR1
SCHEMBL7441884 0.82
SCHEMBL3336728 0.77
SCHEMBL9201057 0.69
SCHEMBL760162 0.67 POLB (0.39)
SCHEMBL4696518 0.67
SCHEMBL3332425 0.67
SCHEMBL760161 0.67 POLB (0.39)
SCHEMBL2540013 0.67 POLB (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0171159-B1 SUBSTITUTED AZETIDINONE COMPOUNDS, THEIR PREPARATION, AND MEDICAMENTS CONTAINING THEM YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1990-05-30 EP disclosed
US-4719207-A CENTRAL NERVOUS SYSTEM YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1988-01-12 US disclosed
EP-0171159-A1 Substituted azetidinone compounds, their preparation, and medicaments containing them YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1986-02-12 EP disclosed